Ticker Scorecard - CRSP Basics Company: CRISPR Therapeutics AG IPO Date: October 19, 2016 Sector: Healthcare Industry: Biotech Market Cap: $3.41B Activated in VL: True Average Daily Range Avg Daily Range: $1.64 | 2.80% Avg Daily Range (30 D): $0.78 | 1.88% Avg Daily Range (90 D): $0.95 | 2.03% Institutional Daily Volume Avg Daily Volume: 1.08M Avg Daily Volume (30 D): 1.77M Avg Daily Volume (90 D): 1.51M Trade Size Avg Trade Size (Sh.): 64 Avg Trade Size (Sh.) (30 D): 65 Avg Trade Size (Sh.) (90 D): 60 Institutional Trades Total Inst.Trades: 4,950 Avg Inst. Trade: $2.75M Avg Inst. Trade (30 D): $2.22M Avg Inst. Trade (90 D): $2.3M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.85M Avg Closing Trade (30 D): $5.14M Avg Closing Trade (90 D): $5.33M Avg Closing Volume: 70.54K     News Feb 2, 2025 @ 10:35 AM Is Vertex Pharmaceuticals a Buy Now That the FDA A... Source: Cory Renauer Jan 26, 2025 @ 11:30 AM Is Vertex Pharmaceuticals Stock a Buy in 2025? Source: George Budwell Jan 23, 2025 @ 9:15 AM My Top 5 Stocks to Buy in Early 2025 Source: Adria Cimino Jan 16, 2025 @ 8:15 AM My 10 Top Stocks to Buy to Start the New Year Off ... Source: Adria Cimino Jan 14, 2025 @ 9:34 AM Meet the Innovative Growth Stock That Could Rocket... Source: The Motley Fool Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.79 $-1.01 $-1.49 Diluted EPS $-2.79 $-1.01 $-1.49 Revenue $ 202.83M $ .6M $ .52M Gross Profit $ $ $ Net Income / Loss $ -239.59M $ -85.94M $ -126.41M Operating Income / Loss $ -332.4M $ -110.13M $ -151.26M Cost of Revenue $ $ $ Net Cash Flow $ -302.53M $ -258.88M $ -222.95M PE Ratio